Personalized Medical Care & Dedicated International Patient Concierge

4.9 Patient Satisfaction

en-US

Medical Clinic LogoMedical ClinicHome
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesBefore & AfterReviewsAbout UsContact Us
Why Americans Travel to Seoul for Stem Cell Therapy

Medical Guide

Why Americans Travel to Seoul for Stem Cell Therapy

Why some US patients research stem cell therapy in Seoul instead of at home, plus the regulatory difference and the FDA and CDC cautions to weigh first.

Schedule a Consultation

Medically reviewed by Dr. Seok Lee, Lead Physician, Pentaheal Medical Group

If you are an American exploring stem cell therapy and have found yourself reading about clinics in Seoul rather than in your own city, you are not alone, and you are also not making a simple decision. The choice touches on regulation, science, cost, logistics, and personal risk tolerance all at once. This article tries to explain, honestly and without cheerleading, why some patients in the United States look abroad for regenerative treatment, and it places those reasons side by side with the cautions that the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) want every traveler to understand. The goal is not to persuade you that any destination or clinic is superior. It is to help you think clearly.

Two facts belong at the very top, because they frame everything else. First, stem cell and other regenerative therapies are, in general, not approved by the U.S. FDA for safety or effectiveness in treating degenerative, orthopedic, anti-aging, or systemic conditions. Second, South Korea operates its own advanced and regenerative-medicine legal framework, and any permission granted under that framework is a Korean designation, not a form of U.S. FDA approval. Neither of those systems, by itself, proves that a given treatment works. Holding both ideas in mind at the same time is the single most useful thing you can do while you research.

The regulatory difference, explained plainly

The most common reason these therapies are unavailable at home is not that American doctors have never heard of them. It is that they have not cleared the FDA's bar for approval. In the United States, most stem cell and regenerative products are regulated as biological products, and a biologic generally must be approved by the FDA before it can be marketed to treat a disease or condition. The FDA has been direct about this in its public consumer materials: the only stem cell products it has approved consist of blood-forming stem cells derived from umbilical cord blood, used for a narrow set of disorders of the blood-forming system. The agency specifically notes that stem cell products have not been approved for the orthopedic, degenerative, neurological, and cosmetic uses that are frequently advertised.

The FDA does have a pathway meant to speed up promising regenerative work. It is called the Regenerative Medicine Advanced Therapy, or RMAT, designation. It is important to understand what this designation is and is not. RMAT is a tool that can expedite the development and review of a regenerative therapy that targets a serious condition and shows preliminary clinical evidence of promise. It is not an approval, and it is not a shortcut around proving that a treatment is safe and effective. A product with an RMAT designation still has to go through the work of demonstrating benefit before it can be marketed. In other words, the existence of RMAT tells you the FDA takes regenerative medicine seriously as a field; it does not tell you that any particular clinic's therapy has been proven.

South Korea's system works differently. The country has a dedicated legal framework for advanced and regenerative medicine that permits certain regenerative treatments to be provided under its own rules. That is a genuine, factual difference from the United States, and it is often the practical reason a given therapy is simply available in Seoul and not in Chicago or Dallas. But availability under a national framework is not the same thing as proof of effectiveness, and it is not U.S. FDA approval. A therapy can be legally offered somewhere and still be unproven. Keeping the distinction between available and proven clear will protect you from a very common misunderstanding.

The reasons patients actually cite for traveling

People rarely travel for a single reason. When you talk to patients who have looked abroad, a recognizable set of motivations comes up. It helps to separate them and judge each on its own terms rather than letting them blur into a feeling that going abroad must be the answer.

Access to treatments that are unavailable at home

This is the big one. Because many regenerative therapies are not FDA-approved and therefore not offered by mainstream U.S. providers for these indications, patients who want to try them may find that the option effectively does not exist domestically for their condition. South Korea's framework means some of these treatments are provided there. That is a real difference in access. It is also exactly the point where caution matters most, because "I could not get it at home" can quietly turn into "therefore it must be worth getting," and those are not the same statement.

The way care is organized

For some patients the appeal is less about a single injection and more about how the surrounding care is structured. Pentaheal Medical Group, for example, describes a diagnostics-first model. The clinic states that it begins with a functional health evaluation, follows with precision diagnostic testing that may examine metabolic and biochemical markers, nutritional and cellular status, hormones, environmental toxins, and inflammatory markers, and only then moves to a personalized treatment plan. The clinic frames this as treating the root cause rather than only the symptoms. These are descriptions of a process, not promises of a result, and it is worth reading them that way. You can review how the clinic describes its own approach on its official website.

English-language support for international patients

Communication is a recurring worry for anyone considering care abroad, and it is one the CDC flags directly. Pentaheal Medical Group states that it provides a dedicated international patient coordinator and offers virtual consultations before travel, so that some of the planning happens before a patient ever boards a plane. Support like this can reduce the chance of a misunderstanding, but it does not remove the underlying medical risks of a procedure. It simply makes it more likely you will understand what is being proposed and be able to keep records your home doctor can read.

Cost and self-pay considerations

Regenerative therapies are frequently self-pay in both the United States and abroad, because insurance often does not cover treatments that are not FDA-approved for the indication. Some patients look overseas partly for cost reasons. This is a place to slow down. Pentaheal Medical Group does not publish fixed prices; the clinic states that cost and candidacy are confirmed during consultation, and that a deposit is required to confirm a booking, with the balance due before the program begins. More importantly, as the CDC points out, the honest cost comparison never stops at the price of the procedure. Follow-up care for any complication after you return home can be expensive, prolonged, and possibly not covered by your insurance. A realistic budget accounts for that, not just the headline figure.

The cautions the FDA wants you to hear

The FDA's warnings about stem cell products are not fine print, and they apply no matter which country you are in. The agency cautions that unapproved stem cell and regenerative products can carry real safety risks, including administration-site reactions, the ability of cells to move from the placement site and multiply or change into inappropriate cell types, the failure of cells to work as intended, contamination and infection, and, in some documented cases, serious harm such as blindness, tumors, and infections. The FDA is especially wary of any provider who advertises that a single product can treat a wide range of unrelated conditions, because that pattern is a well-known warning sign. If you read marketing anywhere in the world that promises a cure, treat it as a reason to slow down and verify, not a reason to book.

The FDA's consumer alert on regenerative medicine products, which covers stem cells and exosomes, reinforces the same message: most of these products require FDA approval to be marketed for a disease, most have not received it, and patients should be skeptical of claims that outrun the evidence. None of this means the science is worthless. It means the burden of proof has not been met for most uses, and that you should not mistake enthusiasm, testimonials, or availability for proof.

The CDC's medical-tourism checklist

Traveling to another country for care is what the CDC calls medical tourism, and the agency is clear that while it can be reasonable for some people, it carries real risks that deserve their own planning. The CDC highlights several concerns. Infection is possible with any procedure, and complications reported among medical travelers have included wound and bloodstream infections and, in some cases, bloodborne diseases. Antimicrobial resistance is a global issue, and infection-control practices differ between facilities. Quality of care varies because licensing, credentialing, and accreditation requirements differ from country to country. Communication gaps can cause misunderstandings when you are not fluent in the local language. Air travel soon after a procedure can raise the risk of blood clots. And continuity of care is a genuine problem: if a complication appears after you get home, arranging and paying for follow-up can be difficult.

The CDC also gives concrete steps, and they are worth following regardless of destination. Research the provider and the facility, and remember that accreditation alone does not guarantee a good outcome. Make sure you understand exactly what treatment is being proposed and what the evidence for it is. Get a pre-travel consultation with your own healthcare provider, ideally several weeks ahead, to discuss your specific health and the procedure. Consider travel health insurance that includes medical evacuation. Carry copies of your medical records, and collect copies of everything from the facility abroad before you leave, translated if needed. Above all, plan your follow-up and how a complication would be handled before you travel, so continuity is arranged rather than improvised. If you decide to open a conversation with a clinic, the CDC's questions are exactly the ones to ask; you can reach Pentaheal Medical Group through its contact page.

Bottom Line

  • Stem cell and regenerative therapies are generally not U.S. FDA-approved for safety or effectiveness for degenerative, orthopedic, anti-aging, or systemic conditions; South Korea's advanced-regenerative-medicine framework is a Korean designation, not FDA approval, and neither system by itself proves a treatment works.
  • The most common reason these therapies are unavailable in the United States is that they have not cleared FDA approval; the FDA's RMAT designation can speed development of promising therapies but is not itself an approval or proof of benefit.
  • Patients cite real reasons for traveling, including access to treatments unavailable at home, how care is organized, English-language support, and self-pay cost considerations, but "unavailable at home" is not evidence that a therapy is effective.
  • The FDA warns that unapproved stem cell products can carry serious risks and that broad claims to treat many conditions are a warning sign; the CDC identifies infection, variable quality of care, communication gaps, travel-related clots, and difficult follow-up as medical-tourism risks.
  • Before deciding, research the provider, understand the treatment and its evidence, get a pre-travel consultation, plan continuity of care and how complications would be handled, and keep in mind that individual results vary.

Frequently Asked Questions

**Why are these stem cell therapies available in Seoul but not in the United States?**In the United States, most stem cell and regenerative products are regulated as biologics and generally must be FDA-approved before they can be marketed to treat a condition, and most have not been approved for degenerative, orthopedic, anti-aging, or systemic uses. South Korea has a separate legal framework that permits certain regenerative treatments under its own rules. That difference in regulation, not a difference in proof of effectiveness, is usually why a therapy is available in one country and not the other.

**Does a Korean regulatory permission mean the treatment is proven to work?**No. A permission under South Korea's advanced-regenerative-medicine framework means a treatment may be legally provided there under that system. It is not U.S. FDA approval, and it does not establish that the therapy is safe or effective for your situation. Availability and proof of benefit are two different things.

**What is the FDA's RMAT designation, and does it mean a therapy is approved?**The Regenerative Medicine Advanced Therapy designation is a tool that can expedite the development and review of a regenerative therapy for a serious condition that shows preliminary promise. It is not an approval and not a guarantee of effectiveness; a designated product still must be proven safe and effective before it can be marketed.

**What does the FDA warn about stem cell therapies?**The FDA cautions that unapproved stem cell and regenerative products can carry real risks, including administration-site problems, cells moving or multiplying inappropriately, cells failing to work as intended, contamination and infection, and in some cases serious harm. It also warns that claims a single product can treat many unrelated conditions are a well-known red flag.

**What steps does the CDC recommend before traveling abroad for care?**The CDC advises researching the provider and facility, understanding exactly what treatment is proposed and its evidence, getting a pre-travel consultation with your own doctor several weeks ahead, considering travel health insurance with medical evacuation, carrying and collecting your medical records, and arranging your U.S. follow-up and complication plan before you travel.

**How much does treatment at Pentaheal Medical Group cost?**The clinic does not publish fixed prices. It states that cost and candidacy are confirmed at consultation, that a deposit is required to confirm a booking, and that the balance is due before the program begins. When budgeting, the CDC advises also planning for the possible cost of follow-up or emergency care after you return home, which may not be covered by insurance.

This article is for general informational purposes and does not constitute individualized medical advice. Consult a qualified physician about your specific condition.

More Articles

Continue reading our clinical guides.

View All
Korean Board-Certified Care: Safety in Functional Medicine Standards

Korean Board-Certified Care: Safety in Functional Medicine Standards

Chronic spine, joint, and cancer-related pain affects millions of families across South Korea.

Learn More

Learn More
Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Functional Medicine Clinic Seoul Korea | PENTAHEAL Guide

Discover Seoul Korea's top functional medicine clinic for Americans. PENTAHEAL's complete guide to autoimmune, chronic disease and longevity programs in 2026.

Learn More

Learn More
Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Metabolic Syndrome Treatment Seoul Korea: The PENTAHEAL Protocol

Seeking metabolic syndrome treatment Seoul Korea? PENTAHEAL Medical Group offers a 1:1 metabolic reset program led by Dr. Seok Lee. Book your consult today.

Learn More

Learn More

Medical Clinic

Dedicated to evidence-based medical care, personalized treatment planning, and comprehensive support for local and international patients.

Treatments

SpecialtiesServicesMedical TeamSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksBefore & AfterPatient ReviewsPress & Media

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© Medical Clinic. All rights reserved.

Individual clinical results may vary. Please consult a board-certified specialist.